NP39724 Generic and Biosimilar Cancer Medicines
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)contractFind a Tender ↗Ref ocds-h6vhtk-04870b32014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
77
Lots
43
43 awarded
Published
27 Feb 2025
Description
Supply of Generic and Biosimilar Cancer Medicines to NHS Scotland.
Scope
- Reference
- NP39724
- Commercial tool
- Standalone contract
- Contract dates
This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- Scotland
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Logistics | 5 | quality | — |
| — | 95 | price | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 43 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Awarded to
SA
ML
SA
ML
Lots · 43 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 1 | Bendamustine Powder For Solution For Infusion | £123k | cancelled |
| 2 | Capecitabine Tablets | £724k | cancelled |
| 3 | Carboplatin Injections | £677k | cancelled |
| 4 | Cisplatin Injections | £1.4m | cancelled |
| 5 | Cyclophosphamide Injection, Powder For Reconstitution | £305k | cancelled |